News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Both T-DXd and SG are approved for patients with HER2-low TNBC. But which one has the strongest data in support? – Paolo Tarantino
Photo from Paolo Tarantino/Twitter
Jul 28, 2023, 08:26

Both T-DXd and SG are approved for patients with HER2-low TNBC. But which one has the strongest data in support? – Paolo Tarantino

Both T-DXd and SG are approved for patients with HER2-low TNBC. But which one has the strongest data in support?

Which one should be utilized first? Find the answer in our latest letter to the editor, now published on Annals of Oncology, Giuseppe Curigliano, Sara Tolaney.

Click here for full article.

cancer OncoDaily Oncology Paolo Tarantino Research
Special Coverage
Blog
Feb 26, 2025, 09:26
New translational insights on immune activation in refractory gastric cancer presented at AACRIO25 - Agenus
Insight
Feb 26, 2025, 09:24
Paolo Tarantino: Interesting commentary on the SONIA trial by Shani Paluch-Shimon et al.
Blog
Feb 26, 2025, 09:22
Cancer death rates are nearly 60% higher in the UK's most deprived areas - Association of European Cancer Leagues
Blog
Feb 26, 2025, 09:17
Gustave Roussy joins forces with Oman in the signing of a memorandum of understanding
Blog
Feb 26, 2025, 09:13
Horizon: Raising Awareness on Biliary Tract Cancer - Jarurat Care Foundation
Blog
Feb 26, 2025, 09:12
Fresh call to new European Commission on a 'Right to be Forgotten” - European Cancer Organisation
Blog
Feb 26, 2025, 09:07
Afreen Shariff: T minus 2 days to the 2nd ASPIRE and 3rd NICT conference
Blog
Feb 26, 2025, 09:06
Upcoming MASCC Webinar on Innovative Approaches in the Management of Bone Metastasis
Blog
Feb 26, 2025, 09:04
Liang Cheng: Primary Adenocarcinoma of the Urinary Tract and Its Precursors
Insight
Feb 26, 2025, 08:59
Armando Orlandi: Italian excellence leading global cancer research
Blog
Feb 26, 2025, 08:51
Gustave Roussy joins forces with Kuwait in the signing of a memorandum of understanding
Blog
Feb 26, 2025, 08:38
Last call for the NFCR Internship Applications